SEC Form 4 · accession 0001104659-16-130145

SELECTA BIOSCIENCES INC · SELB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners

Director

Director

Director

Period of report

Jun 27, 2016

Accepted (ET)

Jun 29, 2016 · 4:45 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001453687

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F5	Jun 27, 2016	C	506,015	$0.00	A	527,028	I	See Footnote
Common Stock^F2,F5	Jun 27, 2016	C	425,874	$0.00	A	445,576	I	See Footnote
Common Stock^F1,F5	Jun 27, 2016	P	710,000	$14.00	A	1,237,028	I	See Footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Series B Convertible Preferred Stock^F1,F5,F3	—	Jun 27, 2016	C	157,864	D	—	—	Common Stock	157,864	I
Series B Convertible Preferred Stock^F2,F5,F3	—	Jun 27, 2016	C	157,864	D	—	—	Common Stock	157,864	I
Series C Convertible Preferred Stock^F1,F5,F3	—	Jun 27, 2016	C	153,742	D	—	—	Common Stock	153,742	I
Series C Convertible Preferred Stock^F2,F5,F3	—	Jun 27, 2016	C	93,954	D	—	—	Common Stock	93,954	I
Series D Convertible Preferred Stock^F1,F5,F3	—	Jun 27, 2016	C	63,547	D	—	—	Common Stock	63,547	I
Series D Convertible Preferred Stock^F2,F5,F3	—	Jun 27, 2016	C	51,355	D	—	—	Common Stock	51,355	I
Series E Convertible Preferred Stock^F1,F5,F4	—	Jun 27, 2016	C	84,421	D	—	—	Common Stock	130,862	I
Series E Convertible Preferred Stock^F2,F5,F4	—	Jun 27, 2016	C	79,156	D	—	—	Common Stock	122,701	I

F1Held by Leukon Investments LP ("Leukon").
F2Held by TAS Partners, LLC ("TAS").
F3The preferred stock is convertible at any time, at the holder's election and has no expiration date. The preferred stock automatically converted into common stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering.
F4The Series E Convertible Preferred Stock is convertible at any time, at the holder's election and has no expiration date. The Series E Convertible Preferred Stock automatically converted into common stock on an approximately 1-for-1.550115 basis upon the closing of the Issuer's initial public offering.
F5LKST, Inc. is the general partner of Leukon. Timothy Springer is the president of LKST, Inc. and the managing member of TAS. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.